Table 1 Selected Biotechnology Spinouts
Spinout | Spinout business | Spinout financing date | Spinout initial financing (millions) | Spinout IPO | Spinout market cap on 3/11/03 (millions) | Parent | Parent business |
|---|---|---|---|---|---|---|---|
Abgenix | Antibody therapeutics | 1996 | $14 | 1998 | $555.2 | Cell Genesys | Gene therapy |
Affymetrix | Gene chips | 1993 | $21 | 1996 | $1528 | Affymax | Combinatorial chemistry |
Biovitrum | Metabolic disease | 2001 | $130 | Private | N/A | Pharmacia | Pharmaceuticals |
Guilford | Neurology products | 1993 | $2.5 | 1994 | $109.6 | Scios | Cardiovascular & inflammatory diseases |
InterMune Pharmaceuticals | Infectious disease | 1999 | $6 | 2000 | $567.2 | Connetics | Dermatology |
Perlegen Sciences | Genome scanning | 2000 | $100 | Private | N/A | Affymetrix | Gene chips |
ZymoGenetics | Therapeutic proteins | 2000 | $150 | 2002 | $367.3 | Novo Nordisk | Disease indications |
